Mahindra Lifespace Developers Limited will hold an earnings presentation regarding its performance for the 3rd quarter and nine months ended December 31, 2025. The presentation, encompassing an overview of the company, its operations, and the Unaudited Standalone and Consolidated Financial Results, has been uploaded to the company website for investors. This announcement was officially released on February 2, 2026.
Strategic Focus and Growth
Mahindra Lifespace Developers is focusing on well-defined strategies to drive profitable growth, aiming for sales between ₹8,000 Cr to ₹10,000 Cr. This includes focusing on premium and mid-premium segments in core markets such as MMR, Pune, and Bengaluru. The company is also working on superior customer experiences through designs and sustainability themes.
Key Highlights
The company reported Q3 residential pre-sales of ₹572 Cr, bringing the 9M total to ₹1,773 Cr. Key launches during the nine-month period included NewHaven, Marina64, Citadel T-L, and Lakewoods H&I. Sustenance sales contributed approximately 60% of the 9M sales. Consolidated Resi/IC sales for 9M stood at ₹2,125 Cr, with a strong PAT delivery of ₹208 Cr. Residential collections for the same period reached ₹1,472 Cr, marking an 8% year-over-year growth.
GDV Additions
For the nine months, the company added GDV (Gross Development Value) of ₹10,600 Cr. Noteworthy projects include Lokhandwala 2, Mulund, Navrat 2, Chembur, Mahalunge, Navy 2 and Matunga.
IC & IC Business
The IC & IC business (Integrated Cities and Industrial Clusters) continues to show good momentum. Existing DTA customer 2 contributed ₹41.7 Cr in revenue. Total revenue from O&M and other income reached ₹27.0 Cr. Overall, the Q3 FY26 total revenue for IC & IC amounted to ₹133.7 Cr.
Financial Position
The company maintains a healthy balance sheet with a net debt-to-equity ratio of -0.12 and a cost of debt at 6.7%. As of December 31, 2025, the total equity stood at ₹3,535 Cr. Sales Residential amounted to ₹572 Cr in Q3 FY26 and ₹1,773 Cr for 9M FY26.
Source: BSE
